Calkrein 50 units (Calidino­genase)

Adult dose

Administer 30~150I.U. per day orally in 3 divided doses (take, administer). The dose may be adjusted as appropriate according to age and symptoms.

This medication should not be used in people with bleeding, such as patients who have just experienced a cerebral hemorrhage. Additionally, this medication contains lactose, so it should not be used in patients with a genetic condition that prevents proper digestion of lactose. This medication contains a dye called Yellow No. 5, which should be used with caution in individuals who are allergic to it or have had hypersensitivity reactions in the past. If allergic symptoms such as skin rash or itching occur during use, the medication should be stopped immediately. Rarely, symptoms such as palpitations, gastrointestinal discomfort, nausea, vomiting, loss of appetite, abdominal pain, diarrhea, or constipation may occur. Additionally, symptoms such as fever, headache, drowsiness, and fatigue may appear, so caution is needed. Particularly in older individuals, body functions may decline, so dosage should be adjusted to be more cautious when using this medication.

• Rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medication should be stored in a tightly sealed container that is air-tight, and it is recommended to store it at room temperature between 1 and 30 degrees Celsius. This way of storage helps maintain the medication's effectiveness longer.

Appearance

Orange round enteric-coated film tablet

Package unit

30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle